Product Reports Resources Pricing Login Book a demo

Kernel

Biotech & Life Sciences · Culver City, United States · Founded 2016

Neuroscience as a Service enables on-demand access to the world's most advanced brain recording technology MoreLess

Kernel is a pioneering startup in the field of precision neuroscience. They are leveraging their proprietary neurotechnology to create a comprehensive portfolio of brain-based biomarkers. The company's primary goal is to expedite the discovery of treatments, enhance patient outcomes, and revolutionize neuromedicine.

Kernel's main product, Kernel Flow, is a first-of-its-kind neuroimaging headset that collects high-resolution data for precision neuroscience. It uses advanced artificial intelligence (AI) and machine learning (ML) tools to develop new biomarkers and derive actionable insights. The headset is portable and easy to set up, making it possible to bring research-grade neuroimaging to various real-world settings.

Kernel Flow combines high-resolution optical hemodynamic imaging, which provides measures similar to functional Magnetic Resonance Imaging (fMRI), with Electroencephalogram (EEG) measures. This combination provides advanced, multi-modal data for comprehensive insights. The technology is backed by over 5000 unique datasets and has been proven in the field.

Kernel also offers cloud-based analysis tools that provide seamless access to world-class data analyses. These tools are scalable, enabling the processing of individual datasets as well as large-scale population-level analyses.

The company's business model revolves around partnering with research institutions, healthcare providers, and pharmaceutical companies. They aim to improve clinical trial optimization, accelerate treatment development, and enhance neuromedicine by predicting treatment responses and enabling early identification of neurological conditions.

In summary, Kernel is a game-changer in the field of precision neuroscience, offering innovative neurotechnology solutions that have the potential to transform patient care and treatment discovery.

Keywords: Precision Neuroscience, Neurotechnology, Brain-Based Biomarkers, Kernel Flow, Artificial Intelligence, Machine Learning, Neuroimaging, Treatment Discovery, Clinical Trial Optimization, Neuromedicine.

Talent graph

Kernel's talent

Book a demo to see the people
Team profiled 28 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Kernel's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 6 investors entered at this stage
Khosla Ventures
Manta Ray Ventures
Tiny Blue Dot
General Catalyst
Bryan Johnson
Eldridge

Global footprint

Where Kernel has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States84.6%
🇬🇧 United Kingdom7.7%
🇲🇽 Mexico3.9%
🇩🇪 Germany3.9%
4 countries shown

Market sentiment

What the market is saying about Kernel

An AI-synthesized read of the highest-engagement posts about Kernel on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kernel on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.